Rate My Professor Ken-ichiro Kamei

Kamei earned his PhD from Tokyo Institute of Technology in 2003, following BA and MS degrees obtained in 1998 and 2000, respectively. His career trajectory includes a postdoctoral fellowship at the Molecular Biology Institute, University of California, Los Angeles (UCLA), and a staff research associate position at the California NanoSystems Institute at UCLA. He progressed from assistant professor to associate professor at the Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University. Notable publications include 'Integrated-gut-liver-on-a-chip platform as an in vitro human translational model to evaluate pharmacokinetic interactions' (Communications Biology, 2023), 'Three-Dimensional Nanostructured Substrates toward Efficient Generation of Induced Pluripotent Stem Cells' (Small, 2009), 'Primed human pluripotent stem cell-derived blastocyst-like cell aggregates with partial lineage specification' (Regenerative Therapy, 2025), and 'High-Purity Production of Endothelial Cells from Human Pluripotent Stem Cells' (Cell Therapy & Engineering Connect). Kamei serves as Editor-in-Chief of Cell Therapy & Engineering Connect, organizes conferences such as the 1st MENA Conference on Living Therapeutics, and delivers keynote addresses, including at the 4th UAE Anatomy & Cellular Biology Conference in 2025. His work significantly influences bioengineering, stem cell research, and organs-on-chips technologies.